CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: To assess the role of Notch signalling in chronic phase CML and following BCR-ABL inhibition with IM therapy, we compared the gene expression profile of CD34+ cells from NBM donors with paired samples of CD34+ cells from chronic phase CML patients pre- and seven days post-IM therapy.